» Articles » PMID: 38149263

Omicron and Delta Variant Prevalence Detection and Identification During the Fourth COVID-19 Wave in Mexico Using Wastewater-based Epidemiology

Abstract

Objectives: To identify the SARS-CoV-2 variants Delta and Omicron during the fourth wave of the COVID-19 pandemic in Mexico using samples taken from 19 locations in 18 out of the 32 states.

Methods: The genetic material concentration was done with PEG/NaCl precipitation, SARS-CoV-2 presence was confirmed by reverse transcriptase-quantitative polymerase chain reaction assay, the variant detection was carried out using a commercial mutation detection panel kit, and variant/mutation confirmation was done by amplicon sequencing of receptor-binding domain target region. The study used 41 samples.

Results: The Delta variant was confirmed in two samples during August 2021 (Querétaro and CDMX) and in three samples during November 2021 (Aguascalientes, Ciudad Juárez campuses, and Nuevo Leon). In December 2021, another sample with the Delta variant was confirmed in Nuevo Leon. Between January to March 2022 only the presence of Omicron was confirmed, (variant BA.1). Additionally, in this period six samples were identified with the status "Variant Not Determined".

Conclusion: To our knowledge, this study is one of the first to identify Omicron and Delta variants with polymerase chain reaction in Mexico and Latin America and its distribution across the country with 56% Mexican states making it a viable alternative for variant detection without conducting a large quantity of sequencing of clinical tests.

Citing Articles

Interpretation of COVID-19 Epidemiological Trends in Mexico Through Wastewater Surveillance Using Simple Machine Learning Algorithms for Rapid Decision-Making.

Armenta-Castro A, de la Rosa O, Aguayo-Acosta A, Oyervides-Munoz M, Flores-Tlacuahuac A, Parra-Saldivar R Viruses. 2025; 17(1).

PMID: 39861898 PMC: 11768489. DOI: 10.3390/v17010109.


Wastewater Surveillance of SARS-CoV-2 in Zambia: An Early Warning Tool.

Shempela D, Muleya W, Mudenda S, Daka V, Sikalima J, Kamayani M Int J Mol Sci. 2024; 25(16).

PMID: 39201525 PMC: 11354861. DOI: 10.3390/ijms25168839.


In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.

Alamin M, Rahaman M, Ferdousi F, Sarker A, Ali M, Hossen M PLoS One. 2024; 19(7):e0304425.

PMID: 39024368 PMC: 11257407. DOI: 10.1371/journal.pone.0304425.


Seroprevalence of IgM/IgG and Neutralizing Antibodies against SARS-CoV-2 in Unvaccinated Young Adults from Mexico Who Reported Not Having Had a Previous COVID-19 Infection.

Padilla-Borquez D, Matuz-Flores M, Hernandez-Bello J, Sanchez-Zuno G, Garcia-Arellano S, Oregon-Romero E Can J Infect Dis Med Microbiol. 2024; 2024:8871439.

PMID: 38384428 PMC: 10881245. DOI: 10.1155/2024/8871439.

References
1.
Chen J, Wang R, Gilby N, Wei G . Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J Chem Inf Model. 2022; 62(2):412-422. PMC: 8751645. DOI: 10.1021/acs.jcim.1c01451. View

2.
De La Cruz-Hernandez S, Alvarez-Contreras A . Omicron Variant in Mexico: the Fourth COVID-19 Wave. Disaster Med Public Health Prep. 2022; :1-2. PMC: 9314319. DOI: 10.1017/dmp.2022.160. View

3.
Cedro-Tanda A, Gomez-Romero L, Anda-Jauregui G, Garnica-Lopez D, Alfaro-Mora Y, Sanchez-Xochipa S . Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City. Viruses. 2022; 14(3). PMC: 8950183. DOI: 10.3390/v14030545. View

4.
Zarate S, Taboada B, Rosales-Rivera M, Garcia-Lopez R, Munoz-Medina J, Sanchez-Flores A . Omicron-BA.1 Dispersion Rates in Mexico Varied According to the Regional Epidemic Patterns and the Diversity of Local Delta Subvariants. Viruses. 2023; 15(1). PMC: 9863047. DOI: 10.3390/v15010243. View

5.
Specchiarello E, Matusali G, Carletti F, Gruber C, Fabeni L, Minosse C . Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis. Diagnostics (Basel). 2023; 13(9). PMC: 10177602. DOI: 10.3390/diagnostics13091573. View